| # | Drug | Count |
|---|---|---|
| 0 | BASILIXIMAB | 3 |
| 1 | MYCOPHENOLATE MOFETIL | 3 |
| 2 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 3 |
| 3 | TACROLIMUS | 3 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 3 |
| 5 | TACROLIMUS OINTMENT 0.1% | 3 |
| 6 | PREDNISONE | 2 |
| 7 | ADALIMUMAB | 1 |
| 8 | CERTOLIZUMAB PEGOL | 1 |
| 9 | CYCLOBENZAPRINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEGNESIUM OXIDE | 1 | 0.0024 |
| 1 | OXAPROZIN | 1 | 0.0011 |
| 2 | BASILIXIMAB | 3 | 0.0003 |
| 3 | GOLIMUMAB | 1 | 0.0001 |
| 4 | TEDUGLUTIDE | 1 | 0.0001 |
| 5 | GUSELKUMAB | 1 | 0.0000 |
| 6 | PANCRELIPASE | 1 | 0.0000 |
| 7 | TACROLIMUS OINTMENT 0.1% | 3 | 0.0000 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 3 | 0.0000 |
| 9 | MYCOPHENOLATE MOFETIL | 3 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 1 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |
| 2 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 2 | 0.0000 |
| 4 | Corticosteroid [EPC] | 2 | 0.0000 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |